Journal of Biopharmaceutical Statistics

Papers
(The H4-Index of Journal of Biopharmaceutical Statistics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data38
The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring27
Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies13
Multiplicity issues for platform trials with a shared control arm13
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials12
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations10
Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources9
A BAYESIAN ADAPTIVE TWO-STAGE DESIGN FOR PEDIATRIC CLINICAL TRIALS9
Log-rank tests for censored clustered data under generalized randomized block design: Saddlepoint approximation9
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacy9
Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study9
Leverage multiple real-world data sources in single-arm medical device clinical studies9
The use of the win odds in the design of non-inferiority clinical trials9
0.030853033065796